These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 13459025)

  • 1. [Study of the therapeutic value of arsobal in trypanosomiasis caused by Trypanosoma gambiense].
    BURKE J
    Ann Soc Belg Med Trop (1920); 1957 Apr; 37(2):175-90. PubMed ID: 13459025
    [No Abstract]   [Full Text] [Related]  

  • 2. Melarsen in the treatment of Trypanosoma gambiense infection in man.
    BUTLER GC; DUGGAN AJ; HUTCHINSON MP
    Trans R Soc Trop Med Hyg; 1957 Jan; 51(1):69-74. PubMed ID: 13409595
    [No Abstract]   [Full Text] [Related]  

  • 3. [Use of arsobal in the treatment of sleeping sickness].
    NEUJEAN G
    An Inst Med Trop (Lisb); 1952 Sep; 9(3):757-61. PubMed ID: 13092457
    [No Abstract]   [Full Text] [Related]  

  • 4. The treatment of advanced cases of Rhodesian sleeping sickness by Mel. B. and arsobal.
    APTED FI
    Trans R Soc Trop Med Hyg; 1953 Sep; 47(5):387-98. PubMed ID: 13102579
    [No Abstract]   [Full Text] [Related]  

  • 5. Mel W: A field trial in the treatment of Trypanosoma gambiense sleeping sickness.
    WATSON HJ
    Trans R Soc Trop Med Hyg; 1962 May; 56():231-5. PubMed ID: 14005295
    [No Abstract]   [Full Text] [Related]  

  • 6. The treatment of advanced trypanosomiasis rhodesiense with mel B.
    TAUBE E; NIXON LC
    Cent Afr J Med; 1958 Apr; 4(4):141-7. PubMed ID: 13547140
    [No Abstract]   [Full Text] [Related]  

  • 7. [EEG and treatment with Arsobal in human African trypanosomiasis].
    Giordano C; Boa FY; Kouassi B; Piquemal M; Akani F; Yapi P; Sonan T
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):482-3. PubMed ID: 3197245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Arsenical-induced encephalopathy during the treatment of African trypanosomiasis. Apropos of a case with a favorable outcome].
    Pialoux G; Kernbaum S; Vachon F
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):555-6. PubMed ID: 3197251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Products with a melaminyl radical in the treatment of human trypanosomiasis gambiense].
    JONCHERE H; GOMER J; REYNAUD R
    Bull Soc Pathol Exot Filiales; 1953; 46(3):386-96. PubMed ID: 13094465
    [No Abstract]   [Full Text] [Related]  

  • 10. [A trial treatment with eflornithine of trypanosomiasis caused by Trypanosoma brucei gambiense in the Peoples Republic of the Congo].
    Eozenou P; Jannin J; Ngampo S; Carme B; Tell GP; Schechter PJ
    Med Trop (Mars); 1989; 49(2):149-54. PubMed ID: 2507863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Msb and MsbB in the treatment of sleeping sickness due to infection with Trypanosoma gambiense.
    FRIEDHEIM EA
    Ann Trop Med Parasitol; 1953 Dec; 47(4):350-60. PubMed ID: 13125266
    [No Abstract]   [Full Text] [Related]  

  • 12. Berenil in the treatment of Trypanosoma gambiense infection in man.
    HUTCHINSON MP; WATSON HJ
    Trans R Soc Trop Med Hyg; 1962 May; 56():227-30. PubMed ID: 14450244
    [No Abstract]   [Full Text] [Related]  

  • 13. Arsobal in the treatment of Rhodesian sleeping-sickness.
    SILVA MA; CASEIRO A; CARMO RP; DE BASTO AX
    An Inst Med Trop (Lisb); 1954 Jun; 11(2):261-85. PubMed ID: 13314057
    [No Abstract]   [Full Text] [Related]  

  • 14. [Note on the toxicity of MEL B in Trypanosoma rhodesiense sleeping sickness].
    ADRIA ENSSENS K
    Ann Soc Belg Med Trop (1920); 1960 Aug; 40():701-4. PubMed ID: 13681530
    [No Abstract]   [Full Text] [Related]  

  • 15. The therapeutic effect on a group of sleeping sickness patients of a single injection of 3854 R.P. (mel B Friedheim-arsobal Spécia).
    PINTO AR
    Am J Trop Med Hyg; 1954 May; 3(3):464-5. PubMed ID: 13158766
    [No Abstract]   [Full Text] [Related]  

  • 16. [Adrenaline in the prevention and treatment of adverse effects of arsobal therapy. Apropos of 776 cases of human African trypanosomiasis caused by T. gambiense in the Health Service of Fontem (U.R. Cameroon)].
    Sina GC; Triolo N; Cramet B; Suh Bandu M
    Med Trop (Mars); 1982; 42(5):531-6. PubMed ID: 7154902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotypic and phenotypic characterization of Trypanosoma brucei gambiense isolates from Ibba, South Sudan, an area of high melarsoprol treatment failure rate.
    Maina N; Maina KJ; Mäser P; Brun R
    Acta Trop; 2007; 104(2-3):84-90. PubMed ID: 17765860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of experimental trypanosomiasis caused by Trypanosoma brucei brucei in sheep: study of the minimum active dose of melarsoprol].
    Bouteille B; Darde ML; Pestre-Alexandre M; Dumas M; Breton JC; Nicolas JA; Catanzano G; Munoz M
    Bull Soc Pathol Exot Filiales; 1988; 81(3 Pt 2):548-54. PubMed ID: 3197250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Problems in the treatment of human trypanosomiasis.
    FERREIRA FS
    An Inst Med Trop (Lisb); 1952 Sep; 9(3):721-6. PubMed ID: 13092453
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pentylthiarsaphenylmelamine (Mel W) in the treatment of trypanosomiasis due to T. gambiense].
    de JONGH R; FRIEDHEIM EA
    Bull Soc Pathol Exot Filiales; 1959; 52():769-78. PubMed ID: 14407809
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.